Akaal Pharma: Positive Phase-2 Results for S1P1 Agonist in the Treatment of Atopic Dermatitis and Associated Pruritus
SHEPPARTON, VICTORIA, AUSTRALIA, June 10, 2025 /EINPresswire.com/ -- Akaal Pharma Pty Ltd Announces Positive Phase-2 Results for S1P1 Agonist in the Treatment of Atopic Dermatitis and Associated Pruritus A biopharmaceutical company focused on …